Chemotherapy of solid tumors.
D000477:Alkylating Agents / Q000494:pharmacology / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D000963:Antimetabolites / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005493:Folic Acid Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D011687:Purines / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000037:antagonists & inhibitors; D014748:Vinca Alkaloids / Q000494:pharmacology / Q000627:therapeutic use
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D011687:Purines; D011743:Pyrimidines; D014748:Vinca Alkaloids; D006918:Hydroxyurea